v3.26.1
Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders' Deficit (Unaudited) - USD ($)
Total
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2024 $ (25,693,100)   $ 699 $ 369,682,764 $ (395,376,563)
Balance (in shares) at Dec. 31, 2024     6,993,406    
Stock-based compensation 297,229     297,229  
Net income (loss) (3,752,972)       (3,752,972)
Balance at Mar. 31, 2025 (29,148,843)   $ 699 369,979,993 (399,129,535)
Balance (in shares) at Mar. 31, 2025     6,993,406    
Balance at Dec. 31, 2024 (25,693,100)   $ 699 369,682,764 (395,376,563)
Balance (in shares) at Dec. 31, 2024     6,993,406    
Net income (loss) (7,011,560)        
Balance at Jun. 30, 2025 (32,109,213)   $ 699 370,278,211 (402,388,123)
Balance (in shares) at Jun. 30, 2025     6,993,406    
Balance at Mar. 31, 2025 (29,148,843)   $ 699 369,979,993 (399,129,535)
Balance (in shares) at Mar. 31, 2025     6,993,406    
Stock-based compensation 298,218     298,218  
Net income (loss) (3,258,588)       (3,258,588)
Balance at Jun. 30, 2025 (32,109,213)   $ 699 370,278,211 (402,388,123)
Balance (in shares) at Jun. 30, 2025     6,993,406    
Balance at Dec. 31, 2025 $ (140,748,082) $ 4,961,922 $ 4,327 548,047,331 (688,799,740)
Balance (in shares) at Dec. 31, 2025 43,274,398 3,296 43,274,398    
Stock-based compensation $ 8,710,302     8,710,302  
Exercise of tranche A warrants 3,428,304   $ 57 3,428,247  
Exercise of tranche A warrants (in shares)     567,600    
Net income (loss) (125,404,384)       (125,404,384)
Balance at Mar. 31, 2026 (254,013,860) $ 4,961,922 $ 4,384 560,185,880 (814,204,124)
Balance (in shares) at Mar. 31, 2026   3,296 43,841,998    
Balance at Dec. 31, 2025 $ (140,748,082) $ 4,961,922 $ 4,327 548,047,331 (688,799,740)
Balance (in shares) at Dec. 31, 2025 43,274,398 3,296 43,274,398    
Net income (loss) $ (107,938,099)        
Balance at Jun. 30, 2026 $ (213,300,623) $ 11,741,322 $ 4,723 583,432,493 (796,737,839)
Balance (in shares) at Jun. 30, 2026 47,227,259 5,539 47,227,259    
Balance at Mar. 31, 2026 $ (254,013,860) $ 4,961,922 $ 4,384 560,185,880 (814,204,124)
Balance (in shares) at Mar. 31, 2026   3,296 43,841,998    
Stock-based compensation 2,272,840     2,272,840  
Issuance of Series A Preferred Stock upon exercise of tranche A warrants, shares   9,400      
Issuance of Series A Preferred Stock upon exercise of tranche A warrants   $ 27,753,512      
Conversion of Series A Preferred Stock into common shares (in shares)   (7,157)      
Conversion of Series A Preferred Stock into common shares   $ (20,974,112)      
Conversion of Series A Preferred Stock into common shares 20,974,112   $ 339 20,973,773  
Conversion of Series A Preferred Stock into common shares (in shares)     3,385,261    
Net income (loss) 17,466,285       17,466,285
Balance at Jun. 30, 2026 $ (213,300,623) $ 11,741,322 $ 4,723 $ 583,432,493 $ (796,737,839)
Balance (in shares) at Jun. 30, 2026 47,227,259 5,539 47,227,259